Aging Gut Bacteria Drive Sepsis Vulnerability Through Histamine-Barrier Axis
Aged gut microbiota — especially Klebsiella aerogenes — floods the gut with histamine, breaking down intestinal barriers and making elderly patients far more likely to die from sepsis.
Summary
Researchers discovered that aging reshapes the gut microbiome in ways that dramatically increase sepsis mortality. A key culprit is Klebsiella aerogenes, which carries a histidine decarboxylase gene variant allowing it to overproduce histamine. Elevated histamine suppresses Nlrp6, a protein that normally supports autophagy by binding LC3, a process critical for maintaining intestinal barrier integrity. When this HA-Nlrp6-LC3 axis is disrupted, intestinal permeability surges, inflammatory cytokines spike, and outcomes worsen sharply. Fecal microbiota transplant experiments confirmed that aged microbiota — not just aging physiology alone — transfers this vulnerability to young mice. Treatments that reduced histamine or restored Nlrp6 expression improved outcomes in septic mouse models, pointing to a targetable therapeutic pathway for older sepsis patients.
Detailed Summary
Sepsis kills roughly 11 million people annually, and older adults bear a disproportionate burden — those over 65 represent 57.5% of cases, face incidence rates 31 times higher than younger adults, and have twice the one-year mortality. Despite these stark statistics, the biological mechanisms explaining why aging worsens sepsis outcomes have remained poorly defined. This study systematically investigates how aging-driven changes in the gut microbiome compromise the intestinal barrier and amplify sepsis susceptibility.
Using a cecal ligation and puncture (CLP) mouse model, researchers compared aged (22–24 months) and young (8–10 weeks) mice and found that 100% of aged animals died within 36 hours versus roughly 50% of young mice. Aged septic mice showed more severe intestinal histopathology, fewer goblet cells, reduced mucin-2 (Muc2) expression, and lower levels of tight junction proteins (Occludin, Claudin3), autophagy markers (Atg7, LC3II/LC3I), and Nlrp6 compared to young mice. Serum inflammatory markers (TNF-α, IL-1β), intestinal permeability indicators (FITC-dextran, LPS), and colonic cytokine mRNA (Tnf-α, Cxcl1, Ccl2) were all significantly elevated in the aged group.
Critically, when gut microbiota were eliminated with broad-spectrum antibiotics prior to CLP, survival rates and intestinal injury metrics became comparable between aged and young mice — strongly implicating dysbiosis rather than intrinsic aging physiology as the proximate driver. Fecal microbiota transplantation (FMT) from aged versus young septic donors (both human and mouse) into pseudo-germ-free young recipient mice reproduced the age-associated vulnerability, confirming that the microbiome difference itself transfers harm. 16S rDNA sequencing identified Klebsiella aerogenes (K. aero) as significantly enriched in aged hosts. Nontargeted and targeted metabolomics then revealed that histamine (HA) was a key differentially elevated metabolite in aged septic feces, and that K. aero strains carrying a histidine decarboxylase (HDC) gene variant were the principal histamine producers.
Mechanistically, elevated histamine was shown to suppress Nlrp6 expression in intestinal epithelial cells. Nlrp6 normally binds the autophagy protein LC3, facilitating autophagic clearance and maintaining barrier homeostasis. When HA inhibits Nlrp6, this LC3 interaction is lost, autophagy is impaired, inflammatory signaling via NF-κB and MAPK pathways is amplified, and barrier proteins degrade. Genetically engineered K. aero with deleted HDC activity produced less histamine and caused less intestinal damage, while exogenous histamine recapitulated the pathological phenotype. Overexpression of Nlrp6 or pharmacological reduction of histamine levels (using antihistamine or HDC inhibitor strategies) ameliorated intestinal injury and reduced systemic inflammation in septic mice.
These findings establish a mechanistic chain: aging → K. aero enrichment → excess histamine → Nlrp6 suppression → impaired autophagy (HA-Nlrp6-LC3 axis) → intestinal barrier dysfunction → heightened sepsis mortality. The pathway offers multiple potential therapeutic intervention points relevant to the rapidly growing elderly sepsis population.
Key Findings
- All aged CLP mice died within 36 hours vs. ~50% of young mice, with far worse intestinal barrier damage.
- Antibiotic pre-treatment equalized survival between aged and young septic mice, implicating gut microbiota as the key driver.
- Klebsiella aerogenes carrying an HDC gene variant was enriched in aged hosts and identified as the primary histamine producer.
- Histamine suppresses Nlrp6, disrupting its binding to LC3 and impairing autophagy needed for intestinal barrier maintenance.
- Lowering histamine levels or overexpressing Nlrp6 reduced intestinal injury and systemic inflammation in aged septic mice.
Methodology
The study used CLP-induced sepsis in aged and young mice, FMT from human and mouse donors into pseudo-germ-free recipients, and 16S rDNA sequencing alongside nontargeted and targeted fecal metabolomics. Mechanistic validation employed genetically engineered K. aerogenes (HDC-deletion and HDC-overexpression strains) in both in vivo mouse models and in vitro intestinal epithelial cell experiments, supplemented by Western blot, ELISA, FITC-dextran permeability assays, histopathology, and qRT-PCR.
Study Limitations
The study relies primarily on mouse CLP models, which imperfectly replicate human sepsis pathophysiology and immune aging. Human fecal samples were used for FMT validation but clinical outcome data correlating K. aerogenes abundance or histamine levels with patient prognosis were not reported. Long-term safety and efficacy of HDC inhibition or Nlrp6 modulation in aged organisms with complex comorbidities remain untested.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: